Androgen Deprivation Therapy News and Research

RSS
MicroRNA reduces tumor growth, increases cell death in castration-resistant prostate cancer

MicroRNA reduces tumor growth, increases cell death in castration-resistant prostate cancer

Prostate cancer patients more likely to receive medical care matched to level of risk

Prostate cancer patients more likely to receive medical care matched to level of risk

Prostate cancer patients can experience cognitive impairment following androgen deprivation therapy

Prostate cancer patients can experience cognitive impairment following androgen deprivation therapy

Prostate cancer patients who receive androgen deprivation therapy may experience cognitive problems

Prostate cancer patients who receive androgen deprivation therapy may experience cognitive problems

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who receive brachytherapy more likely to be cancer-free five years later

Men who receive brachytherapy more likely to be cancer-free five years later

ArborMetrix's RegistryMetrix analytics platform selected for UNC's urology department

ArborMetrix's RegistryMetrix analytics platform selected for UNC's urology department

Testosterone therapy suppresses some advanced prostate cancers, find Johns Hopkins scientists

Testosterone therapy suppresses some advanced prostate cancers, find Johns Hopkins scientists

Study: Common prostate cancer therapy exposes low-risk patients to more adverse side effects

Study: Common prostate cancer therapy exposes low-risk patients to more adverse side effects

Study explores use of bisphosphonates for men receiving androgen deprivation therapy

Study explores use of bisphosphonates for men receiving androgen deprivation therapy

Study: Certain prostate cancer medications linked to cardiac death risk

Study: Certain prostate cancer medications linked to cardiac death risk

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Study reveals treatment trends for prostate cancer in Japan

Study reveals treatment trends for prostate cancer in Japan

Research roundup: ACA lawsuit primer; ACA strategies in 4 states; competitive plans for those eligible for Medicare and Medicaid

Research roundup: ACA lawsuit primer; ACA strategies in 4 states; competitive plans for those eligible for Medicare and Medicaid

Men with prostate cancer achieve stronger muscles and remain active through playing football

Men with prostate cancer achieve stronger muscles and remain active through playing football

Enzalutamide drug proves effective in stemming progression of prostate cancer

Enzalutamide drug proves effective in stemming progression of prostate cancer

New strategy prolongs survival in men with newly diagnosed, metastatic prostate cancer

New strategy prolongs survival in men with newly diagnosed, metastatic prostate cancer

Radiation plus hormones offers best outcomes for localised prostate cancer

Radiation plus hormones offers best outcomes for localised prostate cancer

6 months of hormonal treatment in addition to radiotherapy improves outcome for prostate cancer

6 months of hormonal treatment in addition to radiotherapy improves outcome for prostate cancer